In its first-quarter 2026 investor letter, Eagle Capital Management highlighted Danaher Corporation (NYSE:DHR) as a newly added position.
Danaher Corporation (NYSE:DHR) is a healthcare and life science tools company that operates through Biotechnology, Life Sciences, and Diagnostics segments
On May 20, 2026, Danaher Corporation (NYSE:DHR) closed at $171.12 per share. One-month return of Danaher Corporation (NYSE:DHR) was -4.17%, and its shares lost 8.73% over the past 52 weeks. Danaher Corporation (NYSE:DHR) has a market capitalization of $118.23 billion.
Eagle Capital Management stated the following regarding Danaher Corporation (NYSE:DHR) in its Q1 2026 investor letter: “We’ve built a position in Danaher Corporation (NYSE:DHR), a leading life sciences company. Danaher sells a broad mix of consumables and tooling that are mission-critical to biological R&D, diagnostic testing, and biopharma drug production. It has high market share, differentiated technology, strong management, and good growth prospects.